MAP3K7 and B-cell chronic lymphocytic leukemia: We also observed decreased MAP3K7 protein expression in SF3B1K700E MEC1 CLL cell lines compared with SF3B1WT cells (Fig 5B), in line with the AS event targeting the transcript to NMD degradation (Li et al, 2021).